Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

September 04, 2015 10:58 AM ET


Company Overview of Arbutus Biopharma Corporation

Executive Profile

Michael J. Abrams Ph.D.

AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 7 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Michael J. Abrams, also known as Mike, Ph.D., has been Managing Director of Tekmira Pharmaceuticals Corporation since July 31, 2015 and served as its Chief Discovery Officer and Executive Vice President of Tekmira Pharmaceuticals Corporation since January 6, 2014. Dr. Abrams serves as Corporate Secretary of Spartan Bioscience, Inc. He serves as Scientific Advisor of Tarix Pharmaceuticals LTD. He has been the Chief Executive Officer and President at Inimex Pharmaceuticals ...

Corporate Headquarters

100-8900 Glenlyon Parkway
Burnaby, British Columbia V5J 5J8


Phone: 604-419-3200
Fax: 604-419-3201

Board Members Memberships

Chief Executive Officer, President and Director
Executive Chairman


BA 1978
Bowdoin College
PhD 1983
Massachusetts Institute of Technology
Unknown/Other Education
University Of Ottawa

Other Affiliations

Annual Compensation

Total Annual Compensation$331,753

Stocks Options

All Other Compensation$8,462
Exercisable Options$80,417
Exercisable Options Value$1,182,752
Unexercisable Options$56,250
Unexercisable Options Value$532,688
Total Value of Options$1,715,439
Total Number of Options$136,667

Total Compensation

Total Annual Cash Compensation$340,215
Total Short Term Compensation$331,753
Other Long Term Compensation$8,462
Total Calculated Compensation$869,730

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Ali Mortazavi Chief Executive (leave of absence) and Director
Silence Therapeutics plc
Peter French B.Sc, M.Sc, Ph.D., MBAChief Executive Officer, Managing Director and Director
Benitec Biopharma Limited
Mark W. Schwartz Ph.D.Chief Executive Officer, President, Director and Member of Ad Hoc (Strategy, Pricing, Etc) Committee
Galena Biopharma, Inc.
Paul C. Grint M.D.Chief Executive Officer, President and Director
Regulus Therapeutics Inc.
Douglas M. Fambrough III, Ph.D.Co-Founder, Chief Executive Officer, President and Director
Dicerna Pharmaceuticals, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Arbutus Biopharma Corporation, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at